uniQure N.V.

NASDAQ:QURE

Biotechnology

Healthcare
$20.23 -2.34%

-$1.13 today

Market cap
$1.42B
Beta
1.00
P/E (TTM)
-14.1
EPS (TTM)
-$3.33
52W Low $8.73High $71.50

Volume 1.16M

Average 1.75M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$177.96M

FY 2025 · Annual

Investing Cash Flow

-$321.62M

FY 2025 · Annual

Financing Cash Flow

$415.40M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income329.59M(126.79M)(308.48M)(239.56M)(198.97M)
Depreciation & Amortization7.3M8.54M11.9M12.64M14.76M
Deferred Income Tax3.21M(1.47M)1.92M2.43M1.59M
Stock-Based Compensation25.64M34.2M35.09M22.26M17.68M
Change in Working Capital(50.48M)(43.38M)81.12M(3.94M)(6.79M)
Accounts Receivables(58.96M)(49.08M)(1.32M)(2.24M)(8.6M)
Inventory0(6.92M)(6.74M)2.42M0
Accounts Payables(727K)9.24M(4.17M)1.52M(2.67M)
Other Working Capital9.2M3.39M93.36M(5.64M)4.47M
Other Non-Cash Items(27.29M)(16.16M)32.51M23.44M(6.23M)
Operating Cash Flow287.96M(145.06M)(145.93M)(182.73M)(177.96M)
Capital Expenditures(17.44M)(17.69M)(7.15M)(3.37M)(439K)
Acquisitions (Net)(49.95M)(1.9M)000
Purchases of Investments0(163.15M)(366.44M)(359.84M)(658.37M)
Sales of Investments00167.91M534.5M337.2M
Other Investing Activities00000
Investing Cash Flow(67.39M)(182.73M)(205.69M)162.97M(321.62M)
Debt Repayment62.5M0370.06M(53.05M)0
Common Stock Issued33.7M1.45M308K2.12M391.9M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(1.33M)0(7.65M)(8.56M)23.5M
Financing Cash Flow94.86M1.45M362.72M(59.49M)415.4M
Effect of Forex Changes(3.76M)(1.83M)2.27M(4.97M)5.49M
Net Change in Cash311.67M(328.18M)13.37M(84.22M)(78.69M)
Free Cash Flow270.52M(162.75M)(153.08M)(186.1M)(177.96M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$199.0M
+ D&A$14.8M
+ Stock-Based Comp$17.7M
+ Deferred Tax$1.6M
- Working Capital-$6.8M
- Other Non-Cash-$6.2M
= Operating Cash Flow-$178.0M
- Capex-$439.0K
= Free Cash Flow-$178.0M

Analysis

FY2025 free cash flow is -$178.0M. FCF conversion is 89.4% of net income. Operating cash flow was -$178.0M, with capex of -$439.0K. The largest bridge item is Stock-Based Comp at $17.7M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 10, 2026
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
4Statement of changes in beneficial ownershipNov 3, 2026
8-KCurrent reportNov 2, 2026

Does QURE generate free cash flow?

uniQure N.V. (QURE) generated -$177.96M of free cash flow in fiscal 2025.

How much operating cash flow does QURE produce?

Operating cash flow was -$177.96M, before capital expenditures of $439,000.00.